Logo

Alembic Pharma Share Price

Alembic Pharma (INR)1010.05-44.7   (-4.2%)

Exchange ScripsBSE533573NSEAPLLTDISININE901L01018

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Alembic Pharma Performance

Market performance
Open price1055
High1055.6
Volumes134021
Prev Close1010.05
Low1000.7
Closing date2025-01-10
Historical performance
1 Year High1303.90
3 Year High1303.90
5 Year High1303.90
1 Year Low823.40
3 Year Low462.30
5 Year Low434.80

Alembic Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
19829
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
32.24
Dividend Yield
Dividend Yield
0.54 %

Alembic Pharma Investment Returns

1 Year
26.2%
3 Years
22.6%
5 Years
81%
10 Years
113.4%

Alembic Pharma Technicals

IndicatorsValueSignal
5-DMA1057.52Bearish
10-DMA1055.4Bearish
20-DMA1051.61Bearish
50-DMA1068.09Bearish
100-DMA1108.52Bearish
200-DMA1053.46Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters2626262626
Foreign Investors11111
Domestic Investors2525252525
Public Investors9140374803765418518689526
Government---------------

Alembic Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income29030505875
Operating Profit96177111924615676
Interest562502177160
Depreciation2727275428681835
Profit Before Tax63183546625413681
Consolidated Net Profit61583420520911465
Adjusted EPS31172758

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital393393393393
Total Reserves47789433125198250277
Minority Interest------------
Total Non-Current Liabilities2852416213612
Total Liabilities63412606377230269614
Capital Work in Progress524460132205819443
Total Assets63412606377230269614

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities80327239552314634
Cash Flow from Investing Activities-3206-4476-3720-8388
Cash Flow from Financing Activitie-4379-2620-2174-5974
Net Cash Inflow / Outflow447144-370272
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 32.24.
  • 3Y Stock Price CAGR of the stock is 7.8.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹9617 Million.
  • The company generated revenue of ₹62286 Million in the previous financial year.

Alembic Pharma

1010.05-44.7   (-4.2%)

Investment Amount: ₹ 94355
Current Value: ₹ 101005
Performance: 7%
P/L: ₹ 6650
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month